Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

BOCEPREVIR vs BOCOCIZUMAB: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

BOCEPREVIR vs BOCOCIZUMAB: Safety Overview

Metric BOCEPREVIR BOCOCIZUMAB
Total FAERS Reports 2,078 122
Deaths Reported 112 1
Death Rate 5.4% 0.8%
Hospitalizations 478 114
Average Patient Age 53.1 yrs 61.8 yrs
% Female Patients 44.4% 27.1%
FDA Approval Date May 13, 2011 N/A
Marketing Status Discontinued N/A